Skip Nav Destination
Issues
1 October 2012
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Highlights
CEBP Focus: Patient Navigation in Cancer Care
The Ohio Patient Navigation Research Program: Does the American Cancer Society Patient Navigation Model Improve Time to Resolution in Patients with Abnormal Screening Tests?
Electra D. Paskett; Mira L. Katz; Douglas M. Post; Michael L. Pennell; Gregory S. Young; Eric E. Seiber; J. Phil Harrop; Cecilia R. DeGraffinreid; Cathy M. Tatum; Julie A. Dean; David M. Murray; for the Ohio Patient Navigation Research Program
Patient Navigation Improves Cancer Diagnostic Resolution: An Individually Randomized Clinical Trial in an Underserved Population
Peter C. Raich; Elizabeth M. Whitley; William Thorland; Patricia Valverde; Diane Fairclough; for the Denver Patient Navigation Research Program
Boston Patient Navigation Research Program: The Impact of Navigation on Time to Diagnostic Resolution after Abnormal Cancer Screening
Tracy A. Battaglia; Sharon M. Bak; Timothy Heeren; Clara A. Chen; Richard Kalish; Stephen Tringale; James O. Taylor; Barbara Lottero; A. Patrick Egan; Nisha Thakrar; Karen M. Freund
Patient Navigation Significantly Reduces Delays in Breast Cancer Diagnosis in the District of Columbia
Heather J. Hoffman; Nancy L. LaVerda; Heather A. Young; Paul H. Levine; Lisa M. Alexander; Rachel Brem; Larisa Caicedo; Jennifer Eng-Wong; Wayne Frederick; William Funderburk; Elmer Huerta; Sandra Swain; Steven R. Patierno
Hypothesis/Commentary
Research Articles
Adipokines in Plasma and Breast Tissues: Associations with Breast Cancer Risk Factors
Adana A. Llanos; Ramona G. Dumitrescu; Catalin Marian; Kepher H. Makambi; Scott L. Spear; Bhaskar V.S. Kallakury; David J. Perry; Rafael J. Convit; Mary E. Platek; Amy E. Millen; Lucile L. Adams-Campbell; Jo L. Freudenheim; Peter G. Shields
Global Gene Expression Analysis in Cord Blood Reveals Gender-Specific Differences in Response to Carcinogenic Exposure In Utero
Kevin Hochstenbach; Danitsja M. van Leeuwen; Hans Gmuender; Ralf W. Gottschalk; Martinus Løvik; Berit Granum; Unni Nygaard; Ellen Namork; Micheline Kirsch-Volders; Ilse Decordier; Kim Vande Loock; Harrie Besselink; Margareta Törnqvist; Hans von Stedingk; Per Rydberg; Jos C.S. Kleinjans; Henk van Loveren; Joost H.M. van Delft
Variation in IL10 and Other Genes Involved in the Immune Response and in Oxidation and Prostate Cancer Recurrence
Paul J. Dluzniewski; Ming-Hsi Wang; Siqun Lilly Zheng; Angelo M. De Marzo; Charles G. Drake; Helen L. Fedor; Alan W. Partin; Misop Han; M. Daniele Fallin; Jianfeng Xu; William B. Isaacs; Elizabeth A. Platz
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Helen Warren; Frank Dudbridge; Olivia Fletcher; Nick Orr; Nichola Johnson; John L. Hopper; Carmel Apicella; Melissa C. Southey; Maryam Mahmoodi; Marjanka K. Schmidt; Annegien Broeks; Sten Cornelissen; Linda M. Braaf; Kenneth R. Muir; Artitaya Lophatananon; Arkom Chaiwerawattana; Surapon Wiangnon; Peter A. Fasching; Matthias W. Beckmann; Arif B. Ekici; Ruediger Schulz-Wendtland; Elinor J. Sawyer; Ian Tomlinson; Michael Kerin; Barbara Burwinkel; Frederik Marme; Andreas Schneeweiss; Christof Sohn; Pascal Guénel; Thérèse Truong; Pierre Laurent-Puig; Claire Mulot; Stig E Bojesen; Sune F. Nielsen; Henrik Flyger; Børge G Nordestgaard; Roger L. Milne; Javier Benítez; José-Ignacio Arias-Pérez; M. Pilar Zamora; Hoda Anton-Culver; Argyrios Ziogas; Leslie Bernstein; Christina Clarke Dur; Hermann Brenner; Heiko Müller; Volker Arndt; Anne Langheinz; Alfons Meindl; Michael Golatta; Claus R. Bartram; Rita K. Schmutzler; Hiltrud Brauch; Christina Justenhoven; Thomas Brüning; for The GENICA Network; Jenny Chang-Claude; Shan Wang-Gohrke; Ursula Eilber; Thilo Dörk; Peter Schürmann; Michael Bremer; Peter Hillemanns; Heli Nevanlinna; Taru A. Muranen; Kristiina Aittomäki; Carl Blomqvist; Natalia Bogdanova; Natalia Antonenkova; Yuriy Rogov; Marina Bermisheva; Darya Prokofyeva; Guzel Zinnatullina; Elza Khusnutdinova; Annika Lindblom; Sara Margolin; Arto Mannermaa; Veli-Matti Kosma; Jaana M. Hartikainen; Vesa Kataja; Georgia Chenevix-Trench; Jonathan Beesley; Xiaoqing Chen; for kConFab Investigators; Australian Ovarian Cancer Study Group; Diether Lambrechts; Ann Smeets; Robert Paridaens; Caroline Weltens; Dieter Flesch-Janys; Katharina Buck; Sabine Behrens; Paolo Peterlongo; Loris Bernard; Siranoush Manoukian; Paolo Radice; Fergus J. Couch; Celine Vachon; Xianshu Wang; Janet Olson; Graham Giles; Laura Baglietto; Cariona A. McLean; Gianluca Severi; Esther M. John; Alexander Miron; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Irene L. Andrulis; Julia A. Knight; Anna Marie Mulligan; Nayana Weerasooriya; Peter Devilee; Robert A.E.M. Tollenaar; John W.M. Martens; Caroline M. Seynaeve; Maartje J. Hooning; Antoinette Hollestelle; Agnes Jager; Madeleine M.A. Tilanus-Linthorst; Per Hall; Kamila Czene; Jianjun Liu; Jingmei Li; Angela Cox; Simon S. Cross; Ian W. Brock; Malcolm W.R. Reed; Paul Pharoah; Fiona M. Blows; Alison M. Dunning; Maya Ghoussaini; Alan Ashworth; Anthony Swerdlow; Michael Jones; Minouk Schoemaker; Douglas F. Easton; Manjeet Humphreys; Qin Wang; Julian Peto; Isabel dos-Santos-Silva
BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics
Amanda I. Phipps; Daniel D. Buchanan; Karen W. Makar; Andrea N. Burnett-Hartman; Anna E. Coghill; Michael N. Passarelli; John A. Baron; Dennis J. Ahnen; Aung Ko Win; John D. Potter; Polly A. Newcomb
A Two-Stage Evaluation of Genetic Variation in Immune and Inflammation Genes with Risk of Non-Hodgkin Lymphoma Identifies New Susceptibility Locus in 6p21.3 Region
James R. Cerhan; Zachary S. Fredericksen; Anne J. Novak; Stephen M. Ansell; Neil E. Kay; Mark Liebow; Ahmet Dogan; Julie M. Cunningham; Alice H. Wang; Thomas E. Witzig; Thomas M. Habermann; Yan W. Asmann; Susan L. Slager
Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride
Alan R. Kristal; Cathee Till; Catherine M. Tangen; Phyllis J. Goodman; Marian L. Neuhouser; Frank Z. Stanczyk; Lisa W. Chu; Sherfaraz K. Patel; Ian M. Thompson; Juergen K. Reichardt; Ashraful Hoque; Elizabeth A. Platz; William D. Figg; Adrie Van Bokhoven; Scott M. Lippman; Ann W. Hsing
Null Results in Brief
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.